Joanna Phillips

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Spatially identifying regions of tumor recurrence in patients with suspected recurrent glioma using physiologic MRI and machine learning

  npj Digital Medicine · 2026-06-25

• A 3D tumorwide multi-omic atlas of intratumoral heterogeneity in <i>IDH</i> -mutant glioma.

  Journal of Clinical Oncology · 2026-05-27

• IL-6 Supports Development of an Immunosuppressive Microenvironment and Resistance to Therapy in Glioblastoma

  PubMed Central · 2026-04-13

• Abstract A061: Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responses

  Cancer Research · 2026-03-23

• Abstract IA003: Immortality and evolution, partners in the cancer crime

  Cancer Research · 2026-03-23

• Abstract A043: Genomically-tailored multi-agent precision medicine clinical trial for adults with recurrent glioblastoma

  Cancer Research · 2026-03-23

• EXTH-52. Spatially Resolved Antigenic Landscapes In Low-grade Glioma Reveal Targets For Personalized Immunotherapy

  Neuro-Oncology · 2025-11-01

• CTIM-08. OPERATIONAL STRATEGIES AND REGULATORY NAVIGATION OF AN ACADEMIC CAR T-CELL TRIAL FOR GLIOBLASTOMA: EXPERIENCE FROM THE E-SYNC STUDY

  Neuro-Oncology · 2025-11-01

• IMG-120. A Vision Transformer-Based Approach to Predict Glioblastoma Recurrence from Metabolic and Diffusion MRI for Personalizing Radiation Planning

  Neuro-Oncology · 2025-11-01

• DMG-38. Effective targeting of EGFR-driven diffuse midline glioma with X117195, a novel brain-penetrant EGFR-targeting tyrosine kinase inhibitor (TKI)

  Neuro-Oncology Pediatrics · 2025-08-01

• DMG-63. EGFR confers resistance to ONC201 in H3K27M-mutant diffuse midline glioma

  Neuro-Oncology Pediatrics · 2025-08-01

• ETMR-12. Rare Brain Tumor Consortia (RBTC) case series: Insights into primary brainstem ETMRs, a rare and aggressive tumor of childhood

  Neuro-Oncology Pediatrics · 2025-08-01

• LBA-01. Tumor and systemic molecular / immune correlates and patient reported QOL in pediatric CNS and solid tumors treated with PD1 inhibition and conventional versus hypofractionated radiation on PNOC013

  Neuro-Oncology Pediatrics · 2025-08-01

• Abstract 4250: Tumor-wide RNA splicing aberrations generate immunogenic public neoantigens across cancers

  Cancer Research · 2025-04-21 · 1 citations

• Multiplexed epigenetic memory editing using CRISPRoff sensitizes glioblastoma to chemotherapy

  Neuro-Oncology · 2025-02-25 · 15 citations

• Semi-supervised learning for non-invasive radiopathomic mapping of treatment naïve glioma with multi-parametric MRI

  Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition · 2024-11-26

• 155 Sub-clonal antigenic heterogeneity mediates immune evasion in low-grade gliomas

  Regular and Young Investigator Award Abstracts · 2024-11-01

• PATH-53. DNA MUTATION SEQUENCING AND METHYLATION ANALYSIS OF SOMATIC<i>NF1</i> MUTANT IDH-WILDTYPE GLIOBLASTOMA IDENTIFIES THREE EPIGENETIC GROUPS AND<i>CDKN2A/B</i> LOSS AS A NEGATIVE PROGNOSTIC BIOMARKER

  Neuro-Oncology · 2024-11-01

• IMMU-55. TUMOR-WIDE RNA SPLICING ABERRATIONS GENERATE IMMUNOGENIC PUBLIC NEOANTIGENS IN GLIOBLASTOMAS AND OTHER CANCER TYPES

  Neuro-Oncology · 2024-11-01

• 154 Tumor-wide RNA splicing aberrations generate immunogenic public neoantigens across various cancer types

  Regular and Young Investigator Award Abstracts · 2024-11-01